Public consultations - closed
Below are public consultations that have closed. The documents describe the outcomes of these public consultations.
2022
Proposed fees for 2023: Veterinary Medicinal Products
Public consultation
Outcome of the process
Proposed fees 2023: Human Medicines, Compliance Activities, Blood, Tissue Establishments, Organs and Medical Devices
Public consultation
Outcome of the process
Registration of processes exempted under Article 61(5) and applicable requirements under Article 61(6) of the CTR
Public consultation
A document outlining the outcome of the process will be available at a later date.
2021
Proposed fees for veterinary medicinal products 2022
Public consultation
Outcome of the process
Proposed fees for human medicines, compliance activities, blood, tissue establishments and organs and medical devices 2022
Public consultation
Outcome of the process
Proposed fees for clinical trials 2022
Public consultation
Outcome of the process
2020
Proposed fees for human medicines, compliance activities, blood and tissue establishments and organs 2021
Public consultation
Outcome of the process
Proposed fees for medical devices 2021
Public consultation
Outcome of the process
Proposed fees for veterinary medicines 2021
Public consultation
Outcome of the process
HPRA strategic plan 2021 – 2025
Launch of the public consultation
Final Strategic Plan 2021 - 2025
2019
Proposed fees for human medicines, medical devices, veterinary medicines and compliance 2020
Outcome of the process
Proposed fees for veterinary medicines 2020
Public consultation
Outcome of the process
Guide to biosimilars for healthcare professionals
Guide to biosimilars for healthcare professionals
Outcome of the process
2018
Proposed fees for human medicines, compliance activities, blood, tissue establishments and organs 2019
Public consultation
Outcome of the process
Proposed fees for veterinary medicinal products 2019
Public consultation
Outcome of the process
Proposed fees for medical devices 2018
Public consultation
Outcome of the process
Draft framework for multi-stakeholder approach to handling medicines shortages 2018
Draft framework document
Outcome of the process - final framework document